Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Paroxetine approved for new indication

May 17, 1996

Kappa-opioid agonists reported by Pfizer

May 17, 1996

Pfizer claims analgesic bradykinin antagonists

May 17, 1996

Daicel reports neuronal cell protectant

May 10, 1996

Galanthamine effective in delaying AD progression

May 10, 1996

GR-175737: H3 antagonist for cognition disorders

May 10, 1996

Bayer reports K+ channel modulators for CNS disorders

May 10, 1996

New pediatric approval for Zofran in U.K.

May 10, 1996

Taro's antiepileptic drug in development in USA

May 10, 1996

Tocris Cookson will distribute SYM-2206 for research purposes

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...